ClinicalTrials.Veeva

Menu

Lung Cancer Diagnosis and Staging Using Ultrasound Guidance

S

Singapore Health Services (SingHealth)

Status

Completed

Conditions

Lung Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT01623765
2008/458/B

Details and patient eligibility

About

To collect data of all patients who have undergone Endobronchial ultrasound for diagnosis or staging of suspected lung cancer

Full description

Introduction: Endobronchial Ultrasound (EBUS) is a procedure that is performed via flexible bronchoscopy under moderate sedation for visualization of lymph nodes in the chest and biopsy under real-time guidance for the staging of lung cancer or evaluation of enlarged lymph nodes. In addition, lung lesions or masses can be visualized and biopsied in the same sitting. The use of EBUS has enhanced the safety and diagnostic yield of flexible bronchoscopy.

Aim: The data of patients with suspected lung cancer or undiagnosed lymph node enlargement in whom bronchoscopy with EBUS guidance is clinically indicated will be collected prospectively.

Results from EBUS are considered positive if a specific diagnosis is obtained ( eg malignancy) or if lymphocytes are present in the lymph node biopsy, indicating accurate sampling of lymph node. In patients with non-diagnostic EBUS, the results from other procedures will be compared for analysis.

Enrollment

680 patients

Sex

All

Ages

21 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patients who have undergone endobronchial ultrasound

Exclusion Criteria: None

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems